Literature DB >> 17905105

Contemporary prostate biopsy complication rates in community-based urology practice.

Paul R Sieber1, F M Rommel, Chris G Theodoran, Robert D Hong, Michael A Del Terzo.   

Abstract

OBJECTIVES: To evaluate whether the increased number of rectal perforations associated with contemporary transrectal ultrasound-guided, 12-core prostate biopsy, with a periprostatic block, is associated with a greater rate of postprocedural complications.
METHODS: We prospectively studied 1000 patients undergoing contemporary transrectal ultrasound-guided prostate biopsy and compared the rates of complicated urinary tract infection and significant rectal bleeding with the rates in our previous report of complications using a then-standard, 6-core biopsy technique, without a periprostatic block.
RESULTS: Three patients developed complicated urinary tract infections, two of which were with ciprofloxacin-resistant organisms. This was not a significant different statistically from our earlier report. Seven patients had significant rectal bleeding requiring endoscopic intervention. This rate also was not significantly different statistically from our earlier report.
CONCLUSIONS: Our infection and rectal bleeding complications associated with contemporary transrectal ultrasound-guided prostate biopsy were low. We experienced a small, nonstatistically significant, increase in the complicated urinary tract infection rate and a small, nonstatistically significant, increase in the rectal bleeding rate in association with the transition from an eight-core, no periprostatic block, technique to the contemporary technique.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905105     DOI: 10.1016/j.urology.2007.04.019

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Catastrophic sepsis and hemorrhage following transrectal ultrasound guided prostate biopsies.

Authors:  Paul Toren; Roshan Razik; John Trachtenberg
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

2.  Free-hand transperineal targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: single-center experience in China.

Authors:  Qing Zhang; Wei Wang; Rong Yang; Gutian Zhang; Bing Zhang; Weiping Li; Haifeng Huang; Hongqian Guo
Journal:  Int Urol Nephrol       Date:  2015-03-29       Impact factor: 2.370

Review 3.  The management of rectal bleeding following transrectal prostate biopsy: A review of the current literature.

Authors:  Mark R Quinlan; Damien Bolton; Rowan G Casey
Journal:  Can Urol Assoc J       Date:  2017-12-22       Impact factor: 1.862

4.  Rectal perforation after aquablation of the prostate: lessons learned the hard way.

Authors:  A J Gross; M J Lipp; R Baumbach; B Becker; K Vogt; C Rosenbaum; C Netsch
Journal:  World J Urol       Date:  2021-03-26       Impact factor: 4.226

5.  Risk factors for acute prostatitis after transrectal biopsy of the prostate.

Authors:  Sang Jin Kim; Sun Il Kim; Hyun Soo Ahn; Jong Bo Choi; Young Soo Kim; Se Joong Kim
Journal:  Korean J Urol       Date:  2010-06-21

6.  Single Dose of Levofloxacin versus Three Dosages for Prophylaxis in Prostate Biopsy.

Authors:  Edgar Linden-Castro; Marcela Pelayo-Nieto; Alejandro Alias-Melgar; Fernando Carreño-de la Rosa
Journal:  Int Sch Res Notices       Date:  2014-09-03

7.  Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy.

Authors:  Renato Caretta Chambó; Fabio Hissachi Tsuji; Hamilton Akihissa Yamamoto; Carlos Marcio Nobrega de Jesus
Journal:  Int Braz J Urol       Date:  2015 Jan-Feb       Impact factor: 1.541

8.  Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic Testing.

Authors:  Athanasios Tsalatsanis; Iztok Hozo; Ambuj Kumar; Benjamin Djulbegovic
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

9.  The prevalence of urinary tract infection, or urosepsis following transrectal ultrasound-guided prostate biopsy in a subset of the Saudi population and patterns of susceptibility to flouroquinolones.

Authors:  Sultan S AlKhateeb; Nayf A AlShammari; Mohand A AlZughaibi; Yahya G Ghazwani; Khalid A Alrabeeah; Nasser M Albqami
Journal:  Saudi Med J       Date:  2016-08       Impact factor: 1.484

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.